Productivity and the role of complementary assets in firms' demand for technology innovations

Industrial and Corporate Change

Volumn 19, Issue 3, 2010, Pages 839-869

  Ceccagnoli, Marco ^a   Graham, Stuart J H ^a   Higginsy, Matthew J ^a   Leez, Jeongsik ^a  

^a GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARITY; DEMAND-SIDE MANAGEMENT; INNOVATION; OUTSOURCING; PHARMACEUTICAL INDUSTRY; PRODUCTIVITY; RESEARCH AND DEVELOPMENT; SCIENCE AND TECHNOLOGY; TRANSACTION COST;

EID: 77955761633     PISSN: 09606491     EISSN: 14643650     Source Type: Journal    
DOI: 10.1093/icc/dtq033     Document Type: Article

References (76)

1. Ai, C. R. and E. C. Norton. (2003), 'Interaction terms in logit and probit models,' Economics Letters, 80, 123-129.
2. Arora, A. and M. Ceccagnoli. (2006), 'Patent protection, complementary assets, and firms' incentives for technology licensing,' Management Science, 52, 292-308.
3. Arora, A., M. Ceccagnoli and W. Cohen. (2007), 'Trading knowledge: the determinants of transactions in technology and R&D in the U.S. manufacturing sector,' in N. R. Lamoreaux and K. L. Sokoloff (eds), Financing Innovation in the United States, 1870 to the Present. MIT Press: Cambridge, MA, pp. 365-403.
4. Arora, A., M. Ceccagnoli and W. Cohen. (2008), 'R&D and the patent premium,' International Journal of Industrial Organization, 26, 1153-1179.
5. Arora, A. and A. Fosfuri. (2003), 'Licensing the market for technology,' Journal of Economic Behavior and Organization, 52(2), 277-295.
6. Arora, A., A. Fosfuri and A. Gambardella. (2001), Markets for Technology: Economics of Innovation and Corporate Strategy. MIT Press: Cambridge, MA.
7. Arora, A. and A. Gambardella. (1990), 'Complementarity and external linkages: the strategies of the large firms in biotechnology,' Journal of Industrial Economics, 38(4), 361-379.
8. Arora, A. and A. Gambardella. (1994), 'The changing technology of technical change: general and abstract knowledge and the division of innovative labor,' Research Policy, 23, 523-532.
9. Arora, A. and R. Merges. (2004), 'Specialized supply firms, property rights and firm boundaries,' Industrial and Corporate Change, 13, 451-475.
10. Bresnahan, T. and A. Gambardella. (1998), 'Licensing the market for technology,' in E. Helpman (ed.), General Purpose Technologies and Economic Growth. MIT Press: Cambridge, MA.
11. Cassiman, B. and R. Veugelers. (2006), 'In search of complementarity in innovation strategy: internal R&D and external knowledge acquisition,' Management Science, 52(1), 68-82.
12. Ceccagnoli, M. and M. J. Higgins. (2008), 'Enhancing research productivity through the market for technology,' Unpublished working paper, College of Management, Georgia Institute of Technology.
13. Chan, T., J. A. Nickerson and H. Owan. (2007), 'Strategic management of R&D pipelines with cospecialized investments and technology markets,' Management Science, 53, 667-682.
14. Chesbrough, H. (2003), Open Innovation: The New Imperative for Creating and Profiting from Innovation. Harvard Business School Press: Cambridge, MA.
15. Cohen, W. M. (1995), 'Empirical studies of innovative activity,' in P. Stoneman (ed.), Handbook of the Economics of Innovation and Technological Change. Basil Blackwell: Oxford, pp. 182-264.
16. Cohen, W. M. and D. A. Levinthal. (1989), 'Innovation and learning: the two faces of R&D-Implications for the analysis of R&D investment,' Economic Journal, 99, 569-596.
17. Cohen, W. M., R. Nelson and J. P. Walsh. (2000), 'Protecting their intellectual assets: appropriability conditions and why U.S. manufacturing firms patent or not,' NBER Working Paper, 7522.
18. Cockburn, I. and R. Henderson. (1998), 'Absorptive capacity, coauthoring behavior, and the organization of research in drug discovery,' Journal of Industrial Economics, 46, 157-182.
19. Danzon, P., A. Epstein and S. Nicholson. (2007), 'Mergers and acquisitions in the pharmaceutical and biotech industries,' Managerial and Decision Economics, 28, 307-328.
20. Deloitte ReCap LLC. (2009), http://www.rdna.com (August 20, 2009, date last accessed)
21. DiMasi, J. A. (2001), 'New drug development in the United States from 1963 to 1999,' Clinical Pharmacology & Therapeutics, 69(5), 286-296.
22. Dosi, G. (1988), 'Sources, procedures, and microeconomic effects of innovation,' Journal of Economic Literature, 26, 1120-1171.
23. Evenson, R. (1984), 'International Invention: implications for technology market analysis,' in Z. Griliches (ed.), R&D, Patents, and Productivity. University of Chicago Press: Chicago, IL, pp. 89-123.
24. Fosfuri, A. (2006), 'The licensing dilemma: understanding the determinants of the rate of technology licensing,' Strategic Management Journal, 27, 1141-1158.
25. Fosfuri, A. and M. Giarratana. (2009), 'Masters of war: rivals' product innovation and new advertising in mature product markets,' Management Science, 55, 181-191.
26. Gambardella, A. and M. Giarratana. (2006), 'Innovations for products, innovations for licensing: patents and downstream assets in the software security industry,' Mimeo.
27. Gambardella, A., P. Giuri and A. Luzzi. (2007), 'The market for patents in Europe,' Research Policy, 36, 1163-1183.
28. Gans, J., D. Hsu and S. Stern. (2002), 'When does start-up innovation spur the gale of creative destruction?' Rand Journal of Economics, 33, 571-586.
29. Gans, J. and S. Stern. (2003), 'The product market and the market for "ideas": commercialization strategies for technology entrepreneurs,' Research Policy, 32, 333-350.
30. Graham, S. J. H. (2006), 'The determinants of patentees' use of 'continuation' applications in the United States Patent and Trademark Office, 1980-99,' in B. Andersen (ed.), Intellectual Property Rights: Innovation, Governance and the Institutional Environment. Edward Elgar: Cheltenham, pp. 215-242.
31. Graham, S. J. H. and M. J. Higgins. (2008), 'Comanor and Scherer revisited: do patents proxy for new product introductions?' Unpublished working paper, College of Management, Georgia Institute of Technology.
32. Graham, S. J. H. and M. J. Higgins. (2009), 'Timing new drug introductions: the roles of regulatory rules and firms' complementary assets,' Unpublished working paper, College of Management, Georgia Institute of Technology.
33. Granstrand, O., E. Bohlin, C. Oskarsson and N. Sjöberg. (1992), 'External technology acquisition in large multi-technology corporations,' R&D Management, 22(2), 111-133.
34. Griliches, Z. (1990), 'Patent statistics as economic indicators: a survey,' Journal of Economic Literature, 27, 1661-1707.
35. Hall, B. H. and M. Trajtenberg (2004), 'Uncovering GPTs with patent data,' NBER Working Paper, 10901.
36. Harhoff, D., M. Scherer and K. Vopel (2003), 'Citations, family size, opposition and the value of patent rights,' Research Policy, 32, 1343-1363.
37. Higgins, M. J. (2007), 'The allocation of control rights in pharmaceutical alliances,' Journal of Corporate Finance, 13, 58-75.
38. Higgins, M. J. and D. Rodriguez. (2006), 'The outsourcing of R&D through acquisition in the pharmaceutical industry,' Journal of Financial Economics, 80, 351-383.
39. Jacobides, M. G. and S. G. Winter. (2005), 'The co-evolution of capabilities and transaction costs: explaining the institutional structure of production,' Strategic Management Journal, 26, 395-413.
40. Jensen, E.J. (1987), 'Research expenditures and the discovery of new drugs,' Journal of Industrial Economics, 36(1), 83-95.
41. Kim, Y. J. and N. S. Vonortas. (2006), 'Determinants of technology licensing: the case of licensors,' Managerial and Decision Economics, 27, 235-249.
42. Kim, J., S. J. Lee and G. Marschke. (2004), 'Relation of firm size to R&D productivity,', Unpublished working paper (#04-05), University at Albany, SUNY.
43. Klevorick, A. K., R. C. Levin, R. R. Nelson and S. G. Winter. (1995), 'On the sources and significance of inter-industry differences in technological opportunities,' Research Policy, 24, 185-205.
44. Kline, S. and N. Rosenberg. (1986), 'An overview of innovation,' in R. Landau and N. Rosenberg (eds), The Positive Sum Strategy. National Academy Press: Washington, DC, pp. 275-306.
45. Kogut, B. and U. Zander. (1992), 'Knowledge of the firm, combinative capabilities, and the replication of technology,' Organization Science, 3, 383-397.
46. Kogut, B. and U. Zander. (1993), 'Knowledge of the firm and evolutionary theory of the multinational corporation,' Journal of International Business Studies, 24, 625-645.
47. Kortum, S. (1993), 'Equilibrium R&D and the patent-R&D ratio: U.S. evidence,' American Economic Review, 83(2), 450-457.
48. Lanjouw, J. O. and M. Schankerman. (2004), 'Patent quality and research productivity: measuring innovation with multiple indicators,' Economic Journal, 114, 441-465.
49. Lerner, J. and R.P. Merges. (1998), 'The control of technology alliances: an empirical analysis of the biotechnology industry,' Journal of Industrial Economics, 46, 125-156.
50. Madhok, A. (2002), 'Reassessing the fundamentals and beyond: Ronald Coase, the transaction cost and resource-based theories of the firm and the institutional structure of production,' Strategic Management Journal, 23(6), 535-550.
51. Marenberg, B. J. (2004), 'Recent developments: FDA issues final rule on patent listing requirements and 30-month stays of approval following submission of abbreviated new drug applications,' Biotechnology Law Report, 23(1), 48-51.
52. Masten, S., J. Meehan and E. Snyder. (1991), 'The costs of organization,' Journal of Law, Economics, and Organization, 7, 1-25.
53. Milgrom, P. and J. Roberts. (1990), 'The economics of modern manufacturing: technology, strategy, and organization,' American Economic Review, 80, 511-528.
54. Muris, T., D. Scheffman and P. Spiller. (1992), 'Strategy and transaction costs: the organization of distributors in the carbonated soft drink industry,' Journal of Economics and Management Strategy, 1(1), 82-128.
55. Nelson, R. R. and S. G. Winter. (1982), An Evolutionary Theory of Economic Change. Harvard University Press: Cambridge, MA.
56. Nicholls-Nixon, C. L. and C. Y. Woo. (2003), 'Technology sourcing and output of established firms in a regime of encompassing technological change,' Strategic Management Journal, 24(7), 651-666.
57. Parkhe, A. (1993), 'Strategic alliance structuring: a game theoretic and transaction cost examination of interfirm cooperation,' Academy of Management Journal, 36(4), 794-829.
58. Pisano, G. P. (1990), 'The R&D boundaries of the firm: an empirical analysis,' Administrative Science Quarterly, 35, 153-176.
59. Rigby, D. and C. Zook. (2002), 'Open-market innovation,' Harvard Business Review, 80, 80-89.
60. Rothaermel, F. and D. L. Deeds. (2004), 'Exploration and exploitation alliances in biotechnology: a system of new product development,' Strategic Management Journal, 25, 201-221.
61. Rothaermel, F., M. Hitt and L. Jobe. (2006), 'Balancing vertical integration and strategic outsourcing: effects on product portfolio, product successes, and firm performance,' Strategic Management Journal, 27, 1033-1056.
62. Scherer, F. M. (1983), 'R&D and declining productivity growth,' American Economic Review, 73, 215-218.
63. Scherer, F. M. (2010), 'Pharmaceutical innovation,' in B. Hall and N. Rosenberg (eds), Handbook of the Economics of Innovation. North Holland, pp. 539-574.
64. Simon, H. A. (1947), Administrative Behavior: A Study of Decision-making Processes in Administrative Organizations. The Free Press: New York, NY.
65. Teece, D. J. (1977), 'Technology transfer by multinational firms: the resource cost of transferring technological know-how,' Economic Journal, 87, 242-261.
66. Teece, D. J. (1986), 'Profiting from technological innovation,' Research Policy, 15(6), 285-306.
67. Teece, D. J., G. Pisano and A. Shuen. (1997), 'Dynamic capabilities and strategic management,' Strategic Management Journal, 18(7), 509-533.
68. Thursby, J., R. Jensen and M. Thursby. (2001), 'Objectives, characteristics and outcomes of university licensing: a survey of major U.S. universities,' Journal of Technology Transfer, 26, 59-72.
69. Veugelers, R. (1997), 'Internal R&D expenditures and external technology sourcing,' Research Policy, 26, 303-315.
70. Veugelers, R. and B. Cassiman. (1999), 'Make and buy in innovation strategies: evidence from Belgian manufacturing firms,' Research Policy, 28, 63-80.
71. Voet, M. (2008), The Generic Challenge: Understanding Patents, FDA & Pharmaceutical Life Cycle Management. Brown Walker Press: Boca Raton, FL.
72. von Hippel, E. (1990), 'Task partitioning: an innovation process variable,' Research Policy, 19, 407-418.
73. von Hippel, E. (1994), 'Sticky information and the locus of problem solving: implications for innovation,' Management Science, 40, 429-439.
74. Williamson, O. E. (1975), Markets and Hierarchies: Analysis and Antitrust Implications. The Free Press: New York.
75. Williamson, O. E. (1985), The Economic Institutions of Capitalism: Firms, Markets, and Relational Contracting. The Free Press: New York.
76. Winter, S. G. (1987), 'Knowledge and competence as strategic assets,' in D.J. Teece (ed.), The Competitive challenge. Balling Publishing Company, pp. 159-184.